CONSULTE AQUI NOSSAS PUBLICAÇÕES EM PERIÓDICOS INTERNACIONAIS

 

  • Prognostic Significance of Baseline Heart Rate and Its Interaction With Beta-Blocker Use in Resistant Hypertension: A Cohort Study. Salles, GF; Cardoso, CRL; Fonseca, LL; Fiszman, R; Muxfeldt, ES. American Journal of Hypertension. 2013 (26):218-26.

 

  • Resistant hypertension: a practical clinical approach. Muxfeldt, ES, De Souza F, Salles, GF. Journal of Human Hypertension, 2013 (27):1-6.

 

  • How to use ambulatory blood pressure monitoring in resistant hypertension. Muxfeldt, ES, Salles, GF. Hypertension Research. 2013 (36): 385-89.

 

  • Appropriate Time Interval to Repeat Ambulatory Blood Pressure Monitoring in Patients With White-Coat Resistant Hypertension. Muxfeldt ES, Fiszman R, De Souza F, Viegas BB, Carvalho-Carlos FO, Salles GF. Hypertension (Dallas, Tex. 1979) 2012 (59):384-89.

 

  • Prevalence and associated factors of subclinical hypercortisolism in patients with resistant hypertension. Martins LC, Conceição FL, Muxfeldt ES, Salles GF. J Hypertens. 2012 May;30(5):967-73.

 

  • Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. Muxfeldt ES, Fiszman R, de Souza F, Viegas B, Oliveira FC, Salles GF. Hypertension. 2012 Feb;59(2):384-9.

 

  • Thresholds of ambulatory blood pressure associated with chronic complications in type 2 diabetes. Cardoso CR, Leite NC, Muxfeldt ES, Salles GF. Am J Hypertens. 2012 Jan;25(1):82-8.

 

  • Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study. Salles GF, Cardoso CR, Pereira VS, Fiszman R, Muxfeldt ES. J Hypertens. 2011 Oct;29(10):2014-23.

 

  • Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Atherosclerosis. 2011 May;216(1):199-204.

 

  • Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients. Salles GF, Teixeira GB, Leite NC, Muxfeldt ES, Cardoso CR. Hypertens Res. 2010 Aug;33(8):819-24.

 

  • Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension. Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. J Hypertens. 2010 Aug;28(8):1715-23.

 

  • Prognostic impact of the ambulatory arterial stiffness index in resistant hypertension. Muxfeldt ES, Cardoso CR, Dias VB, Nascimento AC, Salles GF. J Hypertens. 2010 Jul;28(7):1547-53.

 

  • Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Am Heart J. 2010 May;159(5):833-40.

 

  • Efficacy of spironolactone therapy in patients with true resistant hypertension. de Souza F, Muxfeldt E, Fiszman R, Salles G. Hypertension. 2010 Jan;55(1):147-52.

 

  • A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension. Castelpoggi CH, Pereira VS, Fiszman R, Cardoso CR, Muxfeldt ES, Salles GF. Hypertens Res. 2009 Jul;32(7):591-6.

 

  • Prognostic value of nocturnal blood pressure reduction in resistant hypertension. Muxfeldt ES, Cardoso CR, Salles GF. Arch Intern Med. 2009 May 11;169(9):874-80.

 

  • Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study. Salles GF, Cardoso CR, Muxfeldt ES. J Hypertens. 2009 May;27(5):1094-101.

 

  • Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Salles GF, Cardoso CR, Muxfeldt ES. Arch Intern Med. 2008 Nov 24;168(21):2340-6.

 

  • Pattern of 24-hour ambulatory blood pressure monitoring in type 2 diabetic patients with cardiovascular dysautonomy. Cardoso CR, Leite NC, Freitas L, Dias SB, Muxfeld ES, Salles GF. Hypertens Res. 2008 May;31(5):865-72.

 

  • Ambulatory arterial stiffness index or pulse pressure: which correlates better with arterial stiffness in resistant hypertension? Muxfeldt ES, Fiszman R, Castelpoggi CH, Salles GF. Hypertens Res. 2008 Apr;31(4):607-13.

 

  • Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension? Muxfeldt ES, Salles GF. J Hypertens. 2008 May;26(5):878-84.

 

  • Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval? Salles GF, Cardoso CR, Leocadio SM, Muxfeldt ES. Am J Hypertens. 2008 Jan;21(1):47-53.

 

  • Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES. Hypertension. 2007 Oct;50(4):723-8.

 

  • Factors associated with microalbuminuria in resistant hypertension. Nogueira Ada R, Fernandes AS, Coutinho ES, Salles GF, Muxfeld ES, Bloch KV. Int J Cardiol. 2007 Sep 14;121(1):86-7.

 

  • Importance of the electrocardiographic strain pattern in patients with resistant hypertension. Salles G, Cardoso C, Nogueira AR, Bloch K, Muxfeldt E. Hypertension. 2006 Sep;48(3):437-42.

 

  • True resistant hypertension: is it possible to be recognized in the office? Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. Am J Hypertens. 2005 Dec;18(12 Pt 1):1534-40.

 

  • Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Salles G, Leocádio S, Bloch K, Nogueira AR, Muxfeldt E. Hypertension. 2005 Nov;46(5):1207-12.

 

  • Demographic and clinical characteristics of hypertensive patients in the internal medicine outpatient clinic of a university hospital in Rio de Janeiro. Muxfeldt ES, Nogueira A da R, Salles GF, Bloch KV. Sao Paulo Med J. 2004 May 6;122(3):87-93.

 

  • Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Blood Press Monit. 2003 Oct;8(5):181-5.

 

  • Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial. Bloch KV, Salles GF, Muxfeldt ES, Da Rocha Nogueira A. J Hypertens. 2003 Nov;21(11):2159-65.
UFRJ ProHArt - Programa de Hipertensão Arterial
Desenvolvido por: TIC/UFRJ